Porcine bone marrow stromal cell differentiation on heparin-adsorbed poly(e-caprolactone)-tricalcium phosphate-collagen scaffolds.

We evaluate the potential of heparin as a substrate component for the fabrication of bone tissue engineering constructs using poly(e-caprolactone)-tricalcium phosphate-collagen type I (PCL-TCP-Col) three-dimensional (3-D) scaffolds. First we explored the ability of porcine bone marrow precursor cells (MPCs) to differentiate down both the adipogenic and osteogenic pathways within 2-D culture systems, with positive results confirmed by Oil-Red-O and Alizarin Red staining, respectively. Secondly, we examined the influence of heparin on the interaction and behaviour of MPCs when seeded onto PCL-TCP-Col 3-D scaffolds, followed by their induction into the osteogenic lineage. Our 3-D findings suggest that cell metabolism and proliferation increased between days 1 and 14, with deposition of extracellular matrix also observed up to 28 days. However, no noticeable difference could be detected in the extent of osteogenesis for PCL-TCP-Col scaffolds groups with the addition of heparin compared to identical control scaffolds without the addition of heparin.

[1]  E. Luong-van,et al.  In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. , 2007, Biomaterials.

[2]  D. Moscatelli,et al.  Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. , 1992, The Journal of biological chemistry.

[3]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[4]  J. Turnbull,et al.  Heparan sulfate: decoding a dynamic multifunctional cell regulator. , 2001, Trends in cell biology.

[5]  D. Ornitz,et al.  FGF signaling in the developing endochondral skeleton. , 2005, Cytokine & growth factor reviews.

[6]  R. Schwall,et al.  Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic Activity (*) , 1995, The Journal of Biological Chemistry.

[7]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[8]  A. Caplan.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.

[9]  Li Sun,et al.  Balanced Regulation of Proliferation, Growth, Differentiation, and Degradation in Skeletal Cells , 2007, Annals of the New York Academy of Sciences.

[10]  A. Yayon,et al.  Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Yoshinori Kuboki,et al.  Type I collagen‐induced osteoblastic differentiation of bone‐marrow cells mediated by collagen‐α2β1 integrin interaction , 2000 .

[12]  V. Nurcombe,et al.  Heparan sulfate regulation of progenitor cell fate , 2006, Journal of cellular biochemistry.

[13]  G. Morriss-Kay,et al.  A model for the pharmacological treatment of crouzon syndrome. , 2006, Neurosurgery.

[14]  M. Mohammadi,et al.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Leahy,et al.  Kinetic and structural studies on interactions between heparin or heparan sulfate and proteins of the hedgehog signaling pathway. , 2007, Biochemistry.

[16]  J. Turnbull,et al.  Dynamic biosynthesis of heparan sulphate sequences in developing mouse brain: a potential regulatory mechanism during development. , 2001, Biochemical Society transactions.

[17]  A. Torbicki,et al.  Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism , 2003, Pathophysiology of Haemostasis and Thrombosis.

[18]  C. Kaps,et al.  Porcine mesenchymal stem cells , 2002, Cell and Tissue Research.

[19]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  V. Nurcombe,et al.  The osteoblast-heparan sulfate axis: control of the bone cell lineage. , 2005, The international journal of biochemistry & cell biology.

[21]  R. Brenner,et al.  Low doses and high doses of heparin have different effects on osteoblast‐like Saos‐2 cells in vitro , 2004, Journal of cellular biochemistry.

[22]  J. Weitz,et al.  Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway* , 2006, Journal of Biological Chemistry.

[23]  Dietmar W Hutmacher,et al.  Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. , 2007, Biomaterials.

[24]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[25]  Shan-hui Hsu,et al.  Evaluation of the growth of chondrocytes and osteoblasts seeded into precision scaffolds fabricated by fused deposition manufacturing. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[26]  J. Turnbull,et al.  Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides , 1999, Current Biology.

[27]  Hai-sheng Li,et al.  Engineering of bone tissue with porcine bone marrow stem cells in three-dimensional trabecular metal: in vitro and in vivo studies. , 2003, APMIS. Supplementum.

[28]  L. Joshi,et al.  Carbohydrates in therapeutics. , 2007, Cardiovascular & hematological agents in medicinal chemistry.

[29]  D. Ornitz,et al.  FGF signaling in skeletal development. , 1998, Frontiers in bioscience : a journal and virtual library.

[30]  L. Pinch,et al.  Heparin-induced spinal fractures. , 1979, JAMA.

[31]  A. Irie,et al.  Heparan sulfate is required for bone morphogenetic protein-7 signaling. , 2003, Biochemical and biophysical research communications.

[32]  W. Kett,et al.  Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. , 2002, Analytical biochemistry.

[33]  D. Mazanec,et al.  Drug-induced osteoporosis. , 1989, Cleveland Clinic journal of medicine.

[34]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[35]  H. Kock,et al.  Osteoblast Growth Inhibition by Unfractionated Heparin and by Low Molecular Weight Heparins: An in-vitro Investigation , 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[36]  Laurie G. Smith,et al.  Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction , 1996, The Journal of cell biology.